Page last updated: 2024-08-25

rosiglitazone and Schistosoma japonicum Infection

rosiglitazone has been researched along with Schistosoma japonicum Infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, H; He, YW; Liu, WQ; Zhang, JH	1

Other Studies

1 other study(ies) available for rosiglitazone and Schistosoma japonicum Infection

Article	Year
Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. World journal of gastroenterology, 2008, May-14, Volume: 14, Issue:18 Topics: Actins; Animals; Anthelmintics; Collagen Type I; Collagen Type III; Disease Models, Animal; Hypoglycemic Agents; Interleukin-6; Liver; Liver Cirrhosis; Mice; NF-kappa B; PPAR gamma; Praziquantel; RNA, Messenger; Rosiglitazone; Schistosoma japonicum; Schistosomiasis japonica; Thiazolidinediones; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2008

Article

Year

Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum.

World journal of gastroenterology, 2008, May-14, Volume: 14, Issue:18

Topics: Actins; Animals; Anthelmintics; Collagen Type I; Collagen Type III; Disease Models, Animal; Hypoglycemic Agents; Interleukin-6; Liver; Liver Cirrhosis; Mice; NF-kappa B; PPAR gamma; Praziquantel; RNA, Messenger; Rosiglitazone; Schistosoma japonicum; Schistosomiasis japonica; Thiazolidinediones; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2008